Cargando…

Adjunctive Aripiprazole Versus Placebo for Antipsychotic-Induced Hyperprolactinemia: Meta-Analysis of Randomized Controlled Trials

OBJECTIVE: To compare the safety and efficacy of adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia. METHODS: Population: adult patients presenting with antipsychotic-induced hyperprolactinemia diagnosed by prolactin level with or without prolactin-related symptoms....

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xianbin, Tang, Yilang, Wang, Chuanyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731351/ https://www.ncbi.nlm.nih.gov/pubmed/23936389 http://dx.doi.org/10.1371/journal.pone.0070179

Ejemplares similares

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar, Fatemeh, et al.
Publicado: (2015)

Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
por: Bise, S., et al.
Publicado: (2022)

Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae–Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials
por: Zhang, Ling, et al.
Publicado: (2021)

Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials
por: MENG, Meiling, et al.
Publicado: (2015)

Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole
por: Kotorki, Paraskevi, et al.
Publicado: (2010)

Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia
por: Raveendranthan, Dhanya, et al.
Publicado: (2018)

A Comment on “Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia”
por: Naguy, Ahmed
Publicado: (2018)

Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial
por: Zhao, Jingyuan, et al.
Publicado: (2015)

PM403. Comparison between addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia
por: Lee, Jung Suk, et al.
Publicado: (2016)

Management of antipsychotic-induced hyperprolactinemia
por: Tewksbury, Ashley, et al.
Publicado: (2016)

Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
por: Raghuthaman, G., et al.
Publicado: (2015)

Aripiprazole-induced Hyperprolactinemia in a Young Female with Delusional Disorder
por: Joseph, Sam Padamadan
Publicado: (2016)

Antipsychotics-induced hyperprolactinemia and screening for macroprolactin
por: Ruljancic, Nedjeljka, et al.
Publicado: (2020)

Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials
por: Jiang, Wen-Long, et al.
Publicado: (2020)

Adjunctive aripiprazole for antipsychotic-related hyperprolactinaemia in patients with first-episode schizophrenia: a meta-analysis
por: Zheng, Wei, et al.
Publicado: (2019)

Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
por: Rosenbloom, Arlan L.
Publicado: (2010)

Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Patients with Schizophrenia: A Randomized Controlled Trial
por: Wang, Zhongbao, et al.
Publicado: (2023)

Effect of aripiprazole as an adjunct to atypical antipsychotics on weight and metabolic profile: a 12-week open-label trial
por: Gupta, Bhanu, et al.
Publicado: (2021)

Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone
por: Lee, Bong Ju, et al.
Publicado: (2013)

Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia
por: Fedorenko, Olga Yu., et al.
Publicado: (2020)

Correction: Hyperprolactinemia with antipsychotic drugs in children and adolescents
por: Rosenbloom, Arlan L
Publicado: (2013)

Hyperprolactinemia with antipsychotics and the need for magnetic resonance imaging
por: Molina Liétor, M.D.C., et al.
Publicado: (2022)

Hormonal alterations due to antipsychotic-related hyperprolactinemia
por: Montejo, A.L., et al.
Publicado: (2022)

Effect of adjunctive ranitidine for antipsychotic-induced weight gain: A systematic review of randomized placebo-controlled trials
por: Gu, Xiao-Jing, et al.
Publicado: (2017)

Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Luan, Shuxin, et al.
Publicado: (2018)

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
por: Tasaki, Minami, et al.
Publicado: (2021)

Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2021)

Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis
por: Lu, Zhe, et al.
Publicado: (2022)

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka, Masamichi, et al.
Publicado: (2015)

Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Process
por: Kim, Hye Ri, et al.
Publicado: (2023)

Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
por: Kohen, Izchak, et al.
Publicado: (2010)

Cannabidiol versus placebo as adjunctive treatment in early psychosis: study protocol for randomized controlled trial
por: Dixon, T., et al.
Publicado: (2023)

Antidepressive Effect of Antipsychotics in the Treatment of Schizophrenia: Meta-Regression Analysis of Randomized Placebo-Controlled Trials
por: Miura, Itaru, et al.
Publicado: (2020)

Successful treatment of a prolactinoma with the antipsychotic drug aripiprazole
por: Bakker, Ilse C A, et al.
Publicado: (2016)

Cardiotoxicity of current antipsychotics: Newer antipsychotics or adjunct therapy?
por: Liu, Zheng, et al.
Publicado: (2022)

Adjunctive Peony-Glycyrrhiza decoction for antipsychotic-induced hyperprolactinaemia: a meta-analysis of randomised controlled trials
por: Zheng, Wei, et al.
Publicado: (2018)

Hyperprolactinemia
por: Majumdar, Abha, et al.
Publicado: (2013)

Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
por: Kelly, Deanna L, et al.
Publicado: (2013)

TARC: Turkish aripiprazole consensus report- Aripiprazole use and switching from other antipsychotics to aripiprazole- consensus recommendations by a Turkish multidisciplinary panel
por: Veznedaroglu, Baybars, et al.
Publicado: (2018)

Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial
por: Pagsberg, Anne Katrine, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lj1bdpnjbqln02n92fq1u80ckg